Inspire Medical Systems, based in Minneapolis, Minnesota, develops implantable neurostimulation systems to treat Obstructive Sleep Apnea (OSA). Inspire Medical Systems was formed when the Inspire intellectual property and technology was licensed and spun out from Medtronic in 2007.
Inspire therapy is designed to deliver physiologically-timed, mild stimulation to the hypoglossal nerve on each breathing cycle to prevent airway obstruction during sleep.
Company website: www.inspiresleep.com
FDA IDE approval announced November 30, 2010.
Click here for Inspire Medical’s patents.
Click here for Medtronic’s patents on obstructive sleep apnea (some of these are licensed by Inspire Medical)
Inspire Medical’s IPG Clinical Programmer
Patients control when the therapy is turned on and off via a handheld programmer.